Nasdaq, Dow Jones close in the red amid Hormuz impasse

US stocks ended lower as US-Iran talks remained unresolved amid Strait of Hormuz uncertainty. The Nasdaq fell 0.6% to 26,445, while the Dow and S&P 500 each declined 0.3%. Oil was steady near $82.50/bbl, according to IG’s Axel Rudolph. The article also cites company-specific moves including Nvidia’s $500B AI financing plan and several earnings, bids, and guidance updates.

Original reporting
Published Aug 11, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nasdaq, Dow Jones close in the red amid Hormuz impasse — source image
Decision brief

The 30-second read

$NVDABullishMed
01

Why it matters

Traders get a mix of macro risk-off context (Hormuz impasse) and several same-day idiosyncratic catalysts (hostile bid, analyst downgrade, lease signing, trial timeline update, and quarterly updates).

02

Market read

Macro uncertainty around US-Iran negotiations weighs on broad indices, while multiple company-specific disclosures provide tradable catalysts for individual stocks.

03

What to watch

Oil price stability is described as temporary; if Hormuz negotiations deteriorate, macro risk-off could overwhelm stock-specific positives.

Relevance 6/10Novelty 5/10Timing: late-day market wrap plus same-day company catalysts (downgrade, bid, lease, trial update)

Background

The article frames US equities as drifting lower amid US-Iran inability to reach a peace deal, with oil prices steady around $82.50.

Company-level read

Ticker impact

$NVDABullishMedium confidence
Context

Nvidia is partnering with six financial firms to build AI financing platforms to mobilize more than $500B for data centers and infrastructure.

Expected impact

Mildly positive bias for NVDA sentiment, with follow-through tied to how quickly platforms translate into incremental AI capex.

Evidence & confidence

The article discloses a new financing-platform partnership and a large $500B target, but it is framed as memorandums of understanding and does not quantify near-term revenue impact.

$RIOTBullishMedium confidence
Context

Riot Platforms rose after signing a 20-year data center lease with a leading AI lab valued around $9.1B over the initial term.

Expected impact

Near-term positive momentum likely, with attention on lease terms and whether extension options are likely to be exercised.

Evidence & confidence

The article provides a concrete lease value and duration, but does not include financial statement impact or margin details.

$APPBearishHigh confidence
Context

AppLovin shares fell about 5% after Bank of America downgraded the stock to Neutral citing uncertainty around sustaining 30% long-term revenue growth.

Expected impact

Downward pressure likely until investors get clearer evidence on growth sustainability.

Evidence & confidence

The downgrade is explicitly tied to a specific growth-rate concern and is presented as the immediate driver of the stock move.

$ACBBullishHigh confidence
Context

Aurora Cannabis surged after Curaleaf launched a hostile bid offering Aurora shareholders 0.3463 Curaleaf shares plus $0.75 cash per share.

Expected impact

Elevated volatility with upside skew if competing bids emerge or if Aurora’s board responds favorably.

Evidence & confidence

The article includes bid consideration and a stated premium versus Aurora’s 30-day average, which are key deal variables for traders.

$BHSTBullishMedium confidence
Context

BioHarvest Sciences reported second-quarter revenue of $8.8M, up year over year, and narrowed net loss to $3.7M.

Expected impact

Moderately positive bias, with follow-through dependent on whether the trend continues in subsequent quarters.

Evidence & confidence

The article provides specific quarterly figures, but lacks full guidance or segment detail to gauge durability.

$IMUXBullishMedium confidence
Context

Immunic said its Phase 3 ENSURE-1 and ENSURE-2 trials for vidofludimus calcium remain on track for top-line results by end of 2026.

Expected impact

Supportive for the stock’s probability-weighted outlook, though near-term catalysts remain tied to trial milestones.

Evidence & confidence

The article provides a specific timeline target (end of 2026) but no new efficacy/safety data.

$SCWOBullishMedium confidence
Context

374Water reported preliminary second-quarter revenue above $2.2M, driven largely by a $2M milestone tied to a Factory Acceptance Test.

Expected impact

Short-term positive bias if investors view milestones as repeatable and indicative of pipeline execution.

Evidence & confidence

The article includes revenue and the milestone driver, but does not quantify backlog or future milestone cadence.

$NUAINeutralLow confidence
Context

New Era Energy & Digital backed Texas Governor Greg Abbott’s push for greater oversight of data center development.

Expected impact

Limited price impact unless it translates into measurable business benefits.

Evidence & confidence

The article frames the news as support for oversight and transparency, without revenue or operational impact details.

Market effects

Hormuz impasse keeps oil volatility elevated, which can pressure broad risk appetite while AI financing and data center lease news supports AI infrastructure and semis sentiment.

US indices close lower, suggesting broad risk-off despite idiosyncratic deal and analyst catalysts.

US-Iran negotiation uncertainty can spill into global energy pricing and risk premia, indirectly affecting equity multiples.

Counterpoint

Despite deal and financing headlines, many items are sentiment-driven (memorandums of understanding, trial timeline reaffirmations) and may not translate into near-term earnings.

Key entities

  • Nasdaq

    Closed down 0.6% at 26,445 points.

  • Dow Jones

    Closed down 0.3% at 53,791 points.

  • S&P 500

    Closed down 0.3% at 7,728 points.

  • Nvidia

    Announced partnerships with major financial firms to build AI financing platforms targeting $500B+ in third-party capital.

  • Aurora Cannabis

    Surged on a hostile bid from Curaleaf with stated premium and offer consideration.

Related articles

$NVDAMedAI 8/10

Nvidia Is Near Its High While Its Biggest Chip Peers Sit 18% to 32% Below Theirs. These Are the Chip Stocks to Buy.

Nvidia (NVDA) is near its 52-week high, while peers AMD (AMD), Micron (MU), Broadcom (AVGO), and Marvell (MRVL) trade 18% to 32% below theirs. Nvidia reported $96.2B revenue in Q2 2027, up 106% YoY, with data center revenue at $89B. Broadcom and Marvell raised outlooks, with Broadcom targeting $230B AI revenue by 2028. AMD and Micron also showed strong growth but trade at higher multiples.

$NVDALow

The US paid for a peace deal in Nvidia chips

The US reportedly used the promise of Nvidia AI chips to help secure a peace deal between Armenia and Azerbaijan. The deal involved expanded approval for chip purchases for an Armenian data center project, according to the Wall Street Journal. Nvidia's involvement in the deal highlights the role of advanced semiconductors in US diplomacy. The Firebird facility in Armenia, backed by Nvidia, is part of this strategy. Nvidia executives have acknowledged the role of chips in creating conditions for

$NVDAMedAI 8/10

Nvidia's cash could reshape an AI cloud contender

Nscale, a British AI cloud computing firm, is negotiating to raise up to $3.5B ahead of a U.S. IPO. Nvidia (NVDA) is expected to supply $2B of that financing, making it a major shareholder. Nscale has a $45B contract with Anthropic, which Microsoft and Google previously considered but declined. Nscale's backlog doubled to $103B, largely due to the Anthropic deal. The company was valued at $14.6B in March and aims for a $30B valuation in the new round.